SO

SWISS Orphan EDC at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

SWISS Orphan EDC at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
SO
SWISS Orphan EDC
Biotech
Oncology drug developer based in Switzerland and Texas, focused on hard-to-treat and rare cancers such as glioblastoma.
Talk
Wed Nov 11
11:30–11:40
Immuno-Oncology: SWISS Orphan EDC AG
Drug candidates that cross into the brain, aimed at glioblastoma, a brain tumor with one approved chemotherapy, and later liver and bile duct cancers.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from SWISS Orphan EDC

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction